JORGE E CORTES to Everolimus
This is a "connection" page, showing publications JORGE E CORTES has written about Everolimus.
Connection Strength
0.018
-
Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis. Leuk Lymphoma. 2010 Feb; 51(2):269-74.
Score: 0.018